| Literature DB >> 33158423 |
Patricia Hägglund1,2, Mary Hägg3,4, Eva Levring Jäghagen5, Bengt Larsson6, Per Wester7,8.
Abstract
BACKGROUND: Oral and pharyngeal swallowing dysfunction are common complications in acute stroke patients. This primary aim of this study was to determine whether oral neuromuscular training improves swallowing function in participants with swallowing dysfunction after stroke. A secondary aim was to assess how well results of the timed water-swallow test (TWST) correspond with swallowing dysfunction diagnosed by videofluoroscopy (VFS).Entities:
Keywords: Oral screen; Radiology; Rehabilitation; Swallowing capacity; Swallowing disorder; Videofluoroscopy
Mesh:
Year: 2020 PMID: 33158423 PMCID: PMC7648322 DOI: 10.1186/s12883-020-01980-1
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Fig. 1The oral device (Muppy®) (own image)
Fig. 2The lip force meter, LF100 (MHC1 AB Detector, Gothenburg, Sweden) (own image). LF100 is a device for measuring the force (in newtons) of the buccinators. The handle on the LF100 is connected to the oral device
Fig. 3Orofacial sensory-vibration stimulation using an electric toothbrush. (Left) Stimulation of (1) the buccinator mechanism that activates tongue retraction; (2) the muscles of the floor (m. digastricus anterior abdomen, m. mylohyoideus and m. geniohyoideus) that will lift the hyoid bone forward and upward and activate the swallow reflex; and (3) the lips, enhancing lip closure. (Middle) Stimulation of the front of the tongue that activates and raises the root of the tongue, thus passively activating the receptors in the anterior faucial arch to perform the swallowing reflex and indirectly lift the velum. (Right) Stimulation of the tip of the tongue by downward pressure improves the force of the tongue. All the different movements in the left, middle, and right images also provide sensory stimulation (through n trigeminus, afferent pathway) and feedback as a motor response (through n facialis, efferent pathway), that describe the sensory-motor reflex arc. Illustrations: Anna Jäghagen (own illustration/image)
Fig. 4Flowchart of the subject inclusion and data collection processes
Baseline demographic and clinical characteristics
| Variable | Control group | Intervention group |
|---|---|---|
| Age | 75 [56–90] | 75 [60–85] |
| Sex | ||
| Male | 14 (70) | 11 (55) |
| Female | 6 (30) | 9 (45) |
| Stroke type | ||
| Ischemic | 16 (80) | 16 (80) |
| ICH | 3 (15) | 4 (20) |
| Ischemic and ICH | 1 (5) | – |
| Left hemisphere | 6 (30) | 7 (35) |
| Right hemisphere | 10 (50) | 10 (50) |
| Supratentorial | 15 (75) | 16 (80) |
| Infratentorial | 3 (15) | 4 (20) |
| Supra- and infratentorial | 1 (5) | – |
| Lowered consciousness at hospital admission | 6 (30) | 6 (30) |
Data are presented as n (%) or mean [range]
Abbreviation: ICH Intracerebral hemorrhage
Analysis of swallowing rate, lip force and VFS immediately after treatment and 12 months post-treatment
| Outcome | Control | Within-group differences | Intervention | Within-group differences | Between-groups differences | No. subjects | ||
|---|---|---|---|---|---|---|---|---|
| Median (ranges) | (95% CI) | Median (ranges) | (95% CI) | Control/Intervention | ||||
| Swallowing ratea | ||||||||
| Baseline | 5.1 (0.0–9.5) | 5.3 (0.0–9.2) | 20/20 | |||||
| End of treatment (5 weeks) | 9.2 (1.8–13.4) | 3.6 (1.0–5.8) | 0.001b | 10.3 (3.2–18.7) | 5.3 (2.2–8.6) | < 0.001b | 0.133c | 14/18 |
| 12 months post-treatment | 8.5 (2.9–10.5) | 1.1 (−1.0–6.6) | 0.164b | 13.7 (5.0–28.3) | 9.0 (3.7–13.6) | 0.008b | 0.032c | 9/9 |
| Lip force | ||||||||
| Baseline | 14.0 (3.0–31.0) | 18.5 (7.0–34.0) | 14/18 | |||||
| End-of-treatment (5 weeks) | 14.0 (6.0–46.0) | 2 (−1–10) | 0.079 | 27.0 (11.0–59.0) | 7 (3–13) | < 0.001 | 0.066 | 14/18 |
| 12 months post-treatment | 10.0 (2.0–21.0) | −1 (−3–1) | 0.328 | 31.0 (18.0–51.0) | 12 (4–26) | 0.008 | 0.001 | 9/9 |
| VFS (PAS score) | ||||||||
| Baseline | 6 (1–8) | 3 (1–8) | 13/18 | |||||
| End of treatment (5 weeks) | 1 (1–8) | 0.0 (−6–6) | 0.524b | 2 (1–8) | 0.0 (−2–0) | 0.219b | 0.999 | 11/18 |
| 12 months post-treatment | 1.5 (1–8) | 0.0 (−7–6) | 0.276b | 2 (1–8) | −0.5 (−3–0) | 0.058b | 0.912 | 8/9 |
Abbreviations: VFS videofluoroscopic evaluation of swallowing, PAS Penetration Aspiration Scale, CI confidence interval, TWST timed water-swallow test
aAccording to TWST. Normal swallowing rate is ≥10 mL/s, whereas a rate < 10 mL/s indicates swallowing dysfunction. An increased rate indicates improvement of swallowing function
bWilcoxon signed-rank test
cMann Whitney U-test
Fig. 5Line plots indicating the individual changes in swallowing rate measured by the timed water-swallow test (TWST) and in lip force measured in newtons (N), from baseline (BL) to the end of treatment (EOT) and follow-up 12 months after completed treatment (FO) for the control group and the intervention group
Swallowing dysfunction at baseline according to the VFS
| Baseline | Control | Intervention | |
|---|---|---|---|
| Premature spillage | 0.426a | ||
| Yes | 12 (86) | 13 (72) | |
| No | 2 (14) | 5 (28) | |
| Retention pharynx* | 0.669a | ||
| Yes | 10 (71) | 15 (83) | |
| No | 4 (29) | 3 (17) | |
| Aspiration | 0.178b | ||
| Yes | 8 (57) | 6 (33) | |
| No | 6 (43) | 12 (67) | |
| PAS > 2 | 0.688a | ||
| Yes | 8 (57) | 9 (50) | |
| No | 6 (43) | 9 (50) | |
| One or more dysfunction | NA | ||
| Yes | 14 (100) | 18 (100) | |
| No | 0 (0) | 0 (0) |
Data are given as n (%)
Abbreviations: VFS videofluoroscopy, PAS Penetration Aspiration Scale, NA Not Applicable
*Retention pharynx refers to retention in the vallecula or piriform sinus
aFisher’s exact test
bChi-squared test